Intikeramik Alamasri Industri Tbk PT

The company's capital structure is characterized by a debt-to-equity ratio of 0.29, indicating a relatively conservative leverage position compared to the industry median of 0.45. However, the liquidity position is weak, with a current ratio of 0.4 and zero cash and equivalents on the balance sheet. This suggests the company may face challenges in meeting short-term obligations without external financing.

Profitability metrics are underperforming relative to industry benchmarks. The company reported a net loss of IDR 5.83 billion, resulting in a negative return on equity of -0.8% and a return on assets of -0.5%. These figures are significantly below the industry median ROE of 12% and ROA of 6%, highlighting operational inefficiencies and cost management issues.

Geographically, the company's revenue is concentrated in a single market, with no disclosed international operations. This lack of diversification increases exposure to local economic fluctuations and regulatory changes. The company operates as a single business segment, with no material revenue contributions from distinct product lines or geographic regions.

The company's growth trajectory is mixed. While operating cash flow of IDR 15.05 billion indicates some operational resilience, free cash flow is negative at IDR -2.63 billion, driven by capital expenditures of IDR -1.65 billion. Looking ahead, the company is expected to see a 5% decline in revenue in the current fiscal year, with a projected 3% decline in the following year.

Risk factors include medium liquidity risk due to the absence of cash reserves and a current ratio below 1. The company also faces potential dilution risks, though these are currently assessed as low. Adjustments in the valuation model reflect the company's negative net income and weak liquidity position.

Recent events include a 10-K filing that highlights ongoing cost management initiatives and a strategic focus on improving operational efficiency. No recent earnings call transcripts or material regulatory changes have been disclosed that would significantly alter the company's risk profile.

The company maintains a debt-to-equity ratio of 0.29, matching the cohort median and suggesting manageable leverage levels.

Dilution risk is assessed as low, indicating limited immediate threat to existing shareholder equity value from share issuance.

Capex to revenue ratio is above the cohort median, suggesting the company is investing in future capacity or efficiency.

The company faces high credit risk, signaling significant potential difficulties in meeting its financial obligations or debt repayments.

Cash conversion is -2.58, ranking in the bottom quartile of the cohort and highlighting poor cash generation efficiency.